Search clinical trials for: Asthmatics and non-asthmatic male and female subjects

Total 473177 results

Toray Industries, Inc

Completed

A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment

Renal Impairment

Japan
Actelion

Completed

Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

Healthy

Germany
Repros Therapeutics Inc.

Completed

Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function

Secondary Hypogonadism

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

Healthy Subjects | Pharmacokinetics | Pharmacodynamics | Effect of Race

United Kingdom
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Healthy Subjects

United States
Astellas Pharma Inc

Completed

To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females

Healthy Subjects | Pharmacokinetics

Netherlands
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

Healthy Subjects | Pharmacokinetics | Pharmacodynamics | Japanese | Caucasian

Germany
Pfizer

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

Healthy

Belgium
Sheba Medical Center

Withdrawn

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

Psoriasis

Israel
Mannkind Corporation

Completed

A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.

Healthy Subjects

United States
Mannkind Corporation

Completed

A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers

Diabetes Mellitus | Healthy Subjects

United Kingdom
GlaxoSmithKline

Completed

A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
AstraZeneca

Completed

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214 (TC-5214)

Healthy Subjects

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.

Healthy

United Kingdom
Warner Chilcott
Sanofi

Completed

A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects

Osteoporosis

United States
University Medicine Greifswald

Completed

Impact of Exercise on Retinal Microvascular Regulation Measured by Dynamic Vessel Analysis in Healthy Individuals

Healthy Middle-aged Subjects | Age Range Was 18 to 31 Years | Caucasian Whites | Males and Females

Germany
AstraZeneca

Terminated

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects (JSMAD)

Healthy

United Kingdom
AstraZeneca

Terminated

A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

Healthy | COPD

Sweden
GlaxoSmithKline

Terminated

GSK706769 A First Time in Human Study For Males and Females

Healthy Subjects

United States
GlaxoSmithKline

Completed

GW823296 Repeat Dose Study In Healthy Male And Female Subjects

Healthy Subjects

Australia
Novartis

Completed

Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.

Healthy

United States
AstraZeneca

Completed

AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects

Healthy

United States
AstraZeneca

Completed

Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects

Healthy | Elderly | Tolerability

United States
Novartis

Completed

Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.

Healthy

United States, Canada
AstraZeneca

Completed

AZD5672 Bioavailability Study in Healthy Male and Female Subjects

Rheumatoid Arthritis

United Kingdom
Teva Pharmaceuticals USA

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Healthy

Germany
Novartis

Completed

Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.

Healthy

United States
IRCCS San Raffaele

Completed

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

Diabetes Mellitus, Type 2

Italy
Novartis

Completed

Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.

Healthy

United States
Novartis

Completed

Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.

Healthy

United States
Novartis

Completed

Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

Healthy

United Kingdom
Celgene Corporation

Completed

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
University of Chicago

Not yet recruiting

Kidney Stone Inflammation

Stone, Kidney | Kidney Stone

United States
Universidade Federal Fluminense

Not yet recruiting

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Hemodialysis | Kidney Failure, Chronic | Oxidative Stress

Brazil
Assiut University

Not yet recruiting

Association of Biliary Tract Disorders in Chronic Kidney Disease Patients and Its Related Risk Factors

CKD | Gall Bladder Dysfunction

Egypt
M.D. Anderson Cancer Center

Not yet recruiting

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Advanced Bladder Cancer

United States
University Hospital, Lille

Not yet recruiting

Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation (ESTIME)

Sacral Neuromodulation | Bladder Hyperactivity
Cantonal Hospital Graubuenden
University of Zurich

Not yet recruiting

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease (SIDIA)

Autosomal Dominant Polycystic Kidney Disease

Switzerland

3

Subscribe